Cargando…

1575 A 28-day high-dose safety and pharmacokinetics study of raltegravir in healthy subjects

Detalles Bibliográficos
Autores principales: Krishna, Rajesh, Rizk, Matthew, Schulz, Valerie, Bruggencate-Broeders, Jolanda, Liu, Ran, Larson, Patrick, Abou-Farha, Khalid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781577/
http://dx.doi.org/10.1093/ofid/ofu052.1121
_version_ 1783294988651593728
author Krishna, Rajesh
Rizk, Matthew
Schulz, Valerie
Bruggencate-Broeders, Jolanda
Liu, Ran
Larson, Patrick
Abou-Farha, Khalid
author_facet Krishna, Rajesh
Rizk, Matthew
Schulz, Valerie
Bruggencate-Broeders, Jolanda
Liu, Ran
Larson, Patrick
Abou-Farha, Khalid
author_sort Krishna, Rajesh
collection PubMed
description
format Online
Article
Text
id pubmed-5781577
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-57815772018-03-01 1575 A 28-day high-dose safety and pharmacokinetics study of raltegravir in healthy subjects Krishna, Rajesh Rizk, Matthew Schulz, Valerie Bruggencate-Broeders, Jolanda Liu, Ran Larson, Patrick Abou-Farha, Khalid Open Forum Infect Dis IDWeek 2014 Abstracts Oxford University Press 2014-12 2014-12 /pmc/articles/PMC5781577/ http://dx.doi.org/10.1093/ofid/ofu052.1121 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America
spellingShingle IDWeek 2014 Abstracts
Krishna, Rajesh
Rizk, Matthew
Schulz, Valerie
Bruggencate-Broeders, Jolanda
Liu, Ran
Larson, Patrick
Abou-Farha, Khalid
1575 A 28-day high-dose safety and pharmacokinetics study of raltegravir in healthy subjects
title 1575 A 28-day high-dose safety and pharmacokinetics study of raltegravir in healthy subjects
title_full 1575 A 28-day high-dose safety and pharmacokinetics study of raltegravir in healthy subjects
title_fullStr 1575 A 28-day high-dose safety and pharmacokinetics study of raltegravir in healthy subjects
title_full_unstemmed 1575 A 28-day high-dose safety and pharmacokinetics study of raltegravir in healthy subjects
title_short 1575 A 28-day high-dose safety and pharmacokinetics study of raltegravir in healthy subjects
title_sort 1575 a 28-day high-dose safety and pharmacokinetics study of raltegravir in healthy subjects
topic IDWeek 2014 Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781577/
http://dx.doi.org/10.1093/ofid/ofu052.1121
work_keys_str_mv AT krishnarajesh 1575a28dayhighdosesafetyandpharmacokineticsstudyofraltegravirinhealthysubjects
AT rizkmatthew 1575a28dayhighdosesafetyandpharmacokineticsstudyofraltegravirinhealthysubjects
AT schulzvalerie 1575a28dayhighdosesafetyandpharmacokineticsstudyofraltegravirinhealthysubjects
AT bruggencatebroedersjolanda 1575a28dayhighdosesafetyandpharmacokineticsstudyofraltegravirinhealthysubjects
AT liuran 1575a28dayhighdosesafetyandpharmacokineticsstudyofraltegravirinhealthysubjects
AT larsonpatrick 1575a28dayhighdosesafetyandpharmacokineticsstudyofraltegravirinhealthysubjects
AT aboufarhakhalid 1575a28dayhighdosesafetyandpharmacokineticsstudyofraltegravirinhealthysubjects